Changes in Serum 25-Hydroxyvitamin D and Plasma Intact PTH Levels Following Treatment With Ergocalciferol in Patients With CKD

American Journal of Kidney Diseases

Volumn 50, Issue 1, 2007, Pages 59-68

  Al Aly, Ziyad ^a,b   Qazi, Rizwan A ^b   González, Esther A ^b   Zeringue, Angelique ^a   Martin, Kevin J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

chronic kidney disease; Ergocalciferol; renal osteodystrophy; secondary hyperparathyroidism; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ERGOCALCIFEROL; PARATHYROID HORMONE; STEROL; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ERGOCALCIFEROLS; FEMALE; GLOMERULAR FILTRATION RATE; HOMEOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PARATHYROID HORMONE; RETROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 34250771472     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.04.010     Document Type: Article

References (37)

1. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
2. US Renal Data System. The United States Renal Data Report 2004. Am J Kidney Dis 42 (2003) 1-230
3. Gonzalez E.A., Sachdeva A., Oliver D.A., and Martin K.J. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24 (2004) 503-510
4. LaClair R.E., Hellman R.N., Karp S.L., et al. Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States. Am J Kidney Dis 45 (2005) 1026-1033
5. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., et al. Hypovitaminosis D in medical inpatients. [see comments]. N Engl J Med 338 (1998) 777-783
6. National Kideny Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42 suppl 3 (2003) S1-S201
7. Halloran B.P., Schaefer P., Lifschitz M., Levens M., and Goldsmith R.S. Plasma vitamin D metabolite concentrations in chronic renal failure: Effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab 59 (1984) 1063-1069
8. Lin J., Knight E.L., Hogan M.L., and Singh A.K. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 14 (2003) 2573-2580
9. Levey A.S.G.T., Kusek J.W., Beck G.J., and MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A (abstr)
10. Block G.A., Martin K.J., de Francisco A.L., et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350 (2004) 1516-1525
11. 2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol 9 (1998) 1427-1432
12. Cannata-Andia J.B., and Gomez Alonso C. Vitamin D deficiency: A neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Transplant 17 (2002) 1875-1878
13. Fournier A., Fardellone P., Achard J.M., et al. Importance of vitamin D repletion in uraemia. Nephrol Dial Transplant 14 (1999) 819-823
14. 3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology 146 (2005) 825-834
15. Jones G., Byford V., West S., et al. Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs. Anticancer Res 26 (2006) 2589-2595
16. Boudville N.C., and Hodsman A.B. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Nephrol Dial Transplant 21 (2006) 2621-2624
17. 3. Cell 96 (1999) 507-515
18. Gallieni M., Kamimura S., Ahmed A., et al. Kinetics of monocyte 1 alpha-hydroxylase in renal failure. Am J Physiol 268 (1995) F746-F753
19. Dusso A., Finch J., Delmez J., et al. Extrarenal production of calcitriol. Kidney Int Suppl 29 (1990) S36-S40
20. Ritter C.S., Armbrecht H.J., Slatopolsky E., and Brown A.J. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 70 (2006) 654-659
21. Reichel H., Koeffler H.P., and Norman A.W. The role of the vitamin D endocrine system in health and disease. N Engl J Med 320 (1989) 980-991
22. Levin A., and Li Y.C. Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease?. Kidney Int 68 (2005) 1973-1981
23. Hayes C.E., Nashold F.E., Spach K.M., and Pedersen L.B. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 49 (2003) 277-300
24. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
25. London G.M., Verbeke F.H., Pannier B., Boutouyrie P., Marchais S.J., and Mëtivier F. Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18 (2006) 613-620
26. 3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 65 (2006) 593-597
27. Dusso A.S., Brown A.J., and Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 289 (2005) F8-F28
28. Spina C.S., Tangpricha V., Uskokovic M., Adorinic L., Maehr H., and Holick M.F. Vitamin D and cancer. Anticancer Res 26 (2006) 2515-2524
29. Holick M.F. Vitamin D: Important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 98 (2005) 1024-1027
30. Grant W.B., and Garland C.F. The association of solar ultraviolet B (UVB) with reducing risk of cancer: Multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26 (2006) 2687-2699
31. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., and Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 358 (2001) 1500-1503
32. Merlino L.A., Curtis J., Mikuls T.R., Cerhan J.R., Criswell L.A., and Saag K.G. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study. Arthritis Rheum 50 (2004) 72-77
33. Bouillon R., Eelen G., Verlinden L., Mathieu C., Carmeliet G., and Verstuyf A. Vitamin D and cancer. J Steroid Biochem Mol Biol 102 (2006) 156-162
34. Vieth R. The role of vitamin D in the prevention of osteoporosis. Ann Med 37 (2005) 278-285
35. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., and Dawson-Hughes B. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 293 (2005) 2257-2264
36. Heaney R.P. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 97 (2005) 13-19
37. Andress D.L. Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation. Kidney Int 69 (2006) 33-43